Growth Metrics

Eli Lilly (LLY) Net Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 295.00
Dec 31, 2025 269.00
Sep 30, 2025 -467.00
Jun 30, 2025 1,471.00
Mar 31, 2025 -1,091.00
Dec 31, 2024 2,410.00
Sep 30, 2024 -1,777.00
Jun 30, 2024 67.00
Mar 31, 2024 217.00
Dec 31, 2023 2,401.00
Sep 30, 2023 -2,182.00
Jun 30, 2023 189.00
Mar 31, 2023 -721.00
Dec 31, 2022 562.00
Sep 30, 2022 623.00
Jun 30, 2022 -968.00
Mar 31, 2022 279.00
Dec 31, 2021 519.00
Sep 30, 2021 -424.00
Jun 30, 2021 71.00
Mar 31, 2019 7,221.00
Dec 31, 2018 -99.00
Sep 30, 2018 156.00
Jun 30, 2018 -152.00
Mar 31, 2018 2,616.00
Dec 31, 2017 -3,497.00
Sep 30, 2017 -749.00
Jun 30, 2017 1,943.00
Mar 31, 2017 -1,552.00
Dec 31, 2016 -159.00
Sep 30, 2016 115.00
Jun 30, 2016 479.00
Mar 31, 2016 50.00
Dec 31, 2015 -758.00
Sep 30, 2015 406.00
Jun 30, 2015 67.00
Mar 31, 2015 332.00
Dec 31, 2014 -219.00
Sep 30, 2014 -459.00
Jun 30, 2014 -68.00
Mar 31, 2014 318.00
Dec 31, 2013 -848.00
Sep 30, 2013 50.00
Jun 30, 2013 -729.00
Mar 31, 2013 1,389.00
Dec 31, 2012 -1,063.00
Sep 30, 2012 788.00
Jun 30, 2012 -156.00
Mar 31, 2012 375.00
Dec 31, 2011 -582.00
Sep 30, 2011 96.00
Jun 30, 2011 107.00
Mar 31, 2011 -82.00
Dec 31, 2010 -484.00
Sep 30, 2010 -39.00
Jun 30, 2010 138.00
Mar 31, 2010 733.00
Dec 31, 2009 -205.00
Sep 30, 2009 -441.00
Jun 30, 2009 -413.00